Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 4/20 | 0.54 |
| ▸ | CTSL | P07711 | 4/20 | 0.54 |
| ▸ | CTSK | P43235 | 3/20 | 0.54 |
| ▸ | CTSS | P25774 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | ELANE | P08246 | 2/20 | 0.49 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | CASP7 | P55210 | 1/20 | 0.48 |
| ▸ | CASP6 | P55212 | 1/20 | 0.48 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28870538 | 1.00 | CTSB (0.54) | CTSBCTSLCTSKCTSSMEN1 | |
| SCHEMBL3736355 | 0.91 | CTSB (0.57) | CTSBCTSLCTSKCTSSMEN1 | |
| SCHEMBL30016306 | 0.89 | CTSL (0.55) | CTSBCTSLCTSKCTSSMEN1 | |
| SCHEMBL23748856 | 0.88 | CTSB (0.53) | CTSBCTSLCTSKCTSSMEN1 | |
| SCHEMBL23748855 | 0.88 | CTSB (0.53) | CTSBCTSLCTSKCTSSMEN1 | |
| SCHEMBL3727406 | 0.88 | CTSB (0.54) | CTSBCTSLCTSKCTSSMEN1 | |
| SCHEMBL23535950 | 0.88 | CTSB (0.54) | CTSBCTSLCTSKCTSSMEN1 | |
| SCHEMBL23567826 | 0.86 | CTSB (0.53) | CTSBCTSLCTSKCTSSMEN1 | |
| SCHEMBL28870539 | 0.86 | CTSB (0.53) | CTSBCTSLCTSKCTSSMEN1 | |
| SCHEMBL3725788 | 0.85 | CTSB (0.56) | CTSBCTSLCTSKCTSSMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612357-B2 | Methods of synthesizing 4-valyloxybutyric acid | XWPharma Ltd. (KY) | 2026-04-28 | — | — | US | disclosed |
| US-20240351975-A1 | METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACID | XWPharma Ltd. (KY) | 2024-10-24 | — | — | US | disclosed |
| EP-4077262-B1 | METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACID | XWPHARMA LTD (KY) | 2024-07-24 | — | — | EP | disclosed |
| US-20230357130-A1 | METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACID | XWPharma Ltd. (KY) | 2023-11-09 | — | — | US | disclosed |
| US-11746081-B2 | Methods of synthesizing 4-valyloxybutyric acid | XWPharma Ltd. (KY) | 2023-09-05 | — | — | US | disclosed |
| EP-4077262-A1 | METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACID | XWPharma Ltd. (KY) | 2022-10-26 | — | — | EP | disclosed |
| CN-115244028-A | Synthetic method of 4-valyloxy butyric acid | 凯瑞康宁生物工程有限公司 | 2022-10-25 | — | — | CN | disclosed |
| US-20220234994-A1 | METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACID | XWPharma Ltd. (KY) | 2022-07-28 | — | — | US | disclosed |
| US-11279669-B2 | Methods of synthesizing 4-valyloxybutyric acid | XWPharma Ltd. (KY) | 2022-03-22 | — | — | US | disclosed |
| US-20220055982-A1 | METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACID | XWPharma Ltd. (KY) | 2022-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240351975-A1 | METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACID | GABBR1, GABBR2, GABRB3 | CTSB 2241/4885CTSL 4489/4885CTSK 4539/4885 |
| US-12612357-B2 | Methods of synthesizing 4-valyloxybutyric acid | GABBR1, GABRB1, GABBR2 | CTSB 327/4885CTSL 1157/4885CTSK 2875/4885 |
| US-20230357130-A1 | METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACID | GABBR1, GABBR2, GABRB3 | CTSB 2241/4885CTSL 4489/4885CTSK 4539/4885 |
| US-11279669-B2 | Methods of synthesizing 4-valyloxybutyric acid | GABBR1, GABBR2, GABRB3 | CTSB 2241/4885CTSL 4489/4885CTSK 4539/4885 |
| US-20220055982-A1 | METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACID | GABBR1, GABBR2, GABRB3 | CTSB 2241/4885CTSL 4489/4885CTSK 4539/4885 |
| US-20220234994-A1 | METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACID | GABBR1, GABBR2, GABRB3 | CTSB 2241/4885CTSL 4489/4885CTSK 4539/4885 |
| US-11746081-B2 | Methods of synthesizing 4-valyloxybutyric acid | GABBR1, GABBR2, GABRB3 | CTSB 2241/4885CTSL 4489/4885CTSK 4539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.